(Q28202824)

English

Cantuzumab mertansine, a maytansinoid immunoconjugate directed to the CanAg antigen: a phase I, pharmacokinetic, and biologic correlative study

scientific article (publication date: 15 January 2003)

In more languages
default values for all languages
No label defined

No description defined

Statements

Cantuzumab mertansine, a maytansinoid immunoconjugate directed to the CanAg antigen: a phase I, pharmacokinetic, and biologic correlative study (English)
0 references
0 references
Anthony W Tolcher
0 references
Leonel Ochoa
0 references
Lisa A Hammond
0 references
Amita Patnaik
0 references
Tam Edwards
0 references
Chris Takimoto
0 references
Lon Smith
0 references
Garry Schwartz
0 references
Theresa Mays
0 references
Zdenka L Jonak
0 references
Randall Johnson
0 references
Mark DeWitte
0 references
Helen Martino
0 references
Charlene Audette
0 references
Kate Maes
0 references
Ravi V J Chari
0 references
John M Lambert
0 references
Eric K Rowinsky
0 references
15 January 2003
0 references
21
0 references
2
0 references
211-22
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit